DEF: National HealthCare 2026 Annual Meeting Proxy Statement

National HealthCare Corporation schedules its 2026 Annual Meeting for May 7, 2026, to address director elections and executive compensation.

Summary

• The 2026 Annual Meeting of Shareholders is scheduled for May 7, 2026, in Murfreesboro, Tennessee.
• Shareholders will vote on the re-election of directors Emil E. Hassan, Lisa Piercey, M.D., and William A. Adams.
• An advisory vote on the compensation of Named Executive Officers (Say-on-Pay) will be conducted.
• As of March 13, 2026, there were 15,599,046 shares of Common Stock outstanding.
• The company reported 2025 pre-tax earnings (excluding unrealized gains/losses) of $137,497,000, resulting in a $6,874,841 bonus pool.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a stable, routine governance filing reflecting a company with consistent leadership and a well-defined, long-standing compensation philosophy.

Positives

• Strong shareholder support for executive compensation, with over 96% approval at the 2025 annual meeting.
• Consistent financial performance with adjusted income before income taxes increasing from $45.5 million in 2022 to $137.5 million in 2025.
• Great Place to Work certification maintained in 2024 and 2025.
• Successful transition of leadership roles following the retirement of President and COO R. Michael Ussery.

Negatives

• Base salaries for executive officers are intentionally kept lower than peer companies to emphasize performance-based incentive compensation.
• The company reported late filings for Form 3 for two new directors, William A. Adams and Dr. David R. Gifford.

Risks

• Exposure to cybersecurity threats, which the company manages through an Incident Response Planning Committee and quarterly reviews.
• Reliance on the Master Lease with National Health Investors, Inc. (NHI), which expires on December 31, 2026.
• Potential for professional liability suits and associated legal costs.
• Regulatory and compliance risks inherent in the healthcare industry.

Future Outlook

The company intends to continue its focus on quality care, long-term growth strategies, and effective management of its capital structure. The Board has approved a 3% increase in base salary for Named Executive Officers for 2026 and maintained the bonus plan structure.

Management Comments

• The Board believes that having separate Chairman and CEO positions is currently the best governance model for the company.
• The company designs its compensation program to be as similar as possible for all Partners, irrespective of location, title, or responsibilities.

Industry Context

StockSavvy.ai notes that NHC continues to operate with a conservative, long-tenured leadership team, emphasizing internal promotion and stability. The company's reliance on a master lease with a related party (NHI) is a specific structural feature common in the REIT-operator model within the skilled nursing industry.

Comparison to Industry Standards

• The company uses the S&P Healthcare Index as its primary benchmark for total shareholder return.
• Executive compensation is benchmarked against peer companies of similar size and complexity to ensure market alignment.
• The company's pay-for-performance model is consistent with broader industry trends in the healthcare sector.

Management Changes

Corporate Governance

Legal Proceedings

• None disclosed.

Related Party Transactions

• The company maintains a Master Lease with National Health Investors, Inc. (NHI) for 36 facilities.
• The company manages five centers for National Health Corporation under a contract extending to 2028.
• Several immediate family members of directors and officers are employed by the company in administrative roles.

Stakeholder Impact

• Shareholders are asked to vote on director re-elections and executive compensation.
• Employees (Partners) continue to participate in established benefit programs and the Better Way Program.

Next Steps

• Hold the 2026 Annual Meeting of Shareholders on May 7, 2026.
• File final voting results in a Form 8-K within four business days of the meeting.
• Execute the 2026 compensation plan as approved by the Board.

Key Dates

Recommendation

The filing is a standard annual proxy statement. While it provides transparency into governance and compensation, it does not contain material operational or financial news that would typically trigger a significant shift in share price.

Keywords

National HealthCare Corporation, NHC, Proxy Statement, Healthcare, Executive Compensation, Corporate Governance, Skilled Nursing